AFALX
Price
$11.99
Change
-$0.05 (-0.42%)
Updated
Sep 8 closing price
Net Assets
26.85M
VVIAX
Price
$71.07
Change
-$0.12 (-0.17%)
Updated
Sep 8 closing price
Net Assets
202.84B
Interact to see
Advertisement

AFALX vs VVIAX

Header iconAFALX vs VVIAX Comparison
Open Charts AFALX vs VVIAXBanner chart's image
Applied Finance Dividend Investor
Price$11.99
Change-$0.05 (-0.42%)
VolumeN/A
Net Assets26.85M
Vanguard Value Index Adm
Price$71.07
Change-$0.12 (-0.17%)
VolumeN/A
Net Assets202.84B
AFALX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AFALX vs. VVIAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFALX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. AFALX (26.8M). VVIAX pays higher dividends than AFALX: VVIAX (2.10) vs AFALX (2.00). AFALX was incepted earlier than VVIAX: AFALX (19 years) vs VVIAX (25 years). AFALX (2.04) is less costly to investors than VVIAX (0.05). AFALX is a more actively managed with annual turnover of: 12.78 vs. VVIAX (9.00). AFALX has a lower initial minimum investment than VVIAX: AFALX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. AFALX (6.68). VVIAX return over 5 years is better than : 70.16 vs. AFALX (-5.41).
AFALXVVIAXAFALX / VVIAX
Total Expense Ratio1.210.052,420%
Annual Report Gross Expense Ratio2.040.054,080%
Fund Existence19 years25 years-
Gain YTD7.7897.85099%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets26.8M203B0%
Annual Yield % from dividends2.002.1095%
Returns for 1 year6.687.7486%
Returns for 3 years21.4036.6158%
Returns for 5 years-5.4170.16-8%
Returns for 10 years-5.37131.61-4%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity